Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT?
Crossref DOI link: https://doi.org/10.1007/s00330-016-4397-0
Published Online: 2016-05-14
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schaarschmidt, Benedikt M.
Grueneisen, Johannes
Metzenmacher, Martin
Gomez, Benedikt
Gauler, Thomas
Roesel, Christian
Heusch, Philipp
Ruhlmann, Verena
Umutlu, Lale
Antoch, Gerald
Buchbender, Christian
Text and Data Mining valid from 2016-05-14